Nobody really talks about it... but everyone suffers from it. There's a taboo in the sector.

A topic that stakeholders avoid, that consultants work around, and that internal teams experience in silence: the reality of managing a biocide portfolio when each product relies on multiple active substances (AS), multiple Product Types (PT), multiple usage scenarios, and different regulatory statuses.

The Reality

Let's be honest:

An AS approved in PT1 may still be under evaluation in PT2
A product can still be in transitional regime in one country while already in permanent regime in another
Part of the portfolio is already authorized under BPR, while another part is still transitional
A change in AS/PT status instantly changes the technical, commercial... and legal equation
And all of this must be tracked for all product lines and all subsidiaries

What Practitioners Know

Those who live this profession know:

Managing biocide regulation is not just managing a product
It's managing a moving map of AS x PT x markets x regulatory documents

And this puzzle doesn't come from a lack of competence. It comes from a lack of digital tools worthy of the real complexity.

The Impossible Task

Because nobody—truly nobody—can simultaneously track:

AS/PT status for each active substance
Renewal deadlines
Transitional ↔ permanent implications
Different SPC versions and LoAs
Required product tests
Portfolio impacts, country-by-country obligations...

...all while working under pressure, for multiple product lines, with information scattered across files, emails, and drives.

A Structural Reality

I say this as an engineer, PhD in chemistry, and regulatory expert turned entrepreneur: biocide compliance exceeds human capabilities when not supported by adapted digital architecture.

And this is not an admission of weakness. It's a structural observation.

The New Reality

Today, a biocide portfolio is no longer a "product catalog." It's a dynamic system where each active substance, each PT, each status, each test, and each document influences the whole.

So the real question is no longer: "How do you manage a biocide portfolio?"

The real question is: "How do you create a unified vision in an environment where all pieces are moving at the same time?"

Why We Built AIRCompEX

This is precisely what led us to create AIRCompEX: not a "solution," but a coherence architecture designed for multi-AS/multi-PT portfolios.

Over to You

How do you manage AS/PT complexity today? And what do you really need to have a clear vision?